Actively Recruiting
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-19
100
Participants Needed
1
Research Sites
120 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia
CONDITIONS
Official Title
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must provide voluntary written informed consent
- Diagnosed with non-small cell lung cancer (NSCLC)
- Clinical stage I to IIA with no lymph node involvement (cN0)
- Candidates for surgical tumor removal
You will not qualify if you...
- Pregnancy
- Receiving induction therapy for lung cancer
- Received systemic treatment for other cancers within the last 3 years before lung surgery
- Previous surgery for lung cancer
- Having other active cancers
- Tumor invading the chest wall
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS - Azienda Ospedaliero Universitaria di Bologna
Bologna, Emilia-Romagna, Italy, 40138
Actively Recruiting
Research Team
P
Pietro Bertoglio, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here